Belite Bio Inc ADR (BLTE)

NASD · Healthcare · Biotechnology · USA

Belite Bio Inc ADR is a mid cap company (market value between $2 billion and $10 billion) in the Biotechnology industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the Belite Bio Inc ADR stock.

Our verdict on BLTE

Not valued: We cannot value this company yet.

ETFs with the most weight in BLTE

Browse

Peers in Biotechnology

All 600 Biotechnology stocks

Cheaper than BLTE in Biotechnology

129 more in this industry show a wider margin of safety.

Is BLTE undervalued or overvalued?

We do not publish a verdict on BLTE yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of BLTE?

We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.